Metraipolis › archive › dc_7df5233ccaa7

Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma — Europe PMC PMID:40969261

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40969261
DOI: 10.3389/fonc.2025.1625521
License (as archived): solo-consultazione
Archived: 2026-11-10T03:57:44.123Z
SHA-256 of the archived text: fcebe74f8238dface1b9691a9cdeb56410b223076123a9429545267f2bc8e2ac
Stable URL of this page: https://metraipolis.com/documento/dc_7df5233ccaa7

How to cite

Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma — Europe PMC PMID:40969261 — Europe PMC (en), https://europepmc.org/article/MED/40969261 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7df5233ccaa7 (Metraipolis archive dc_7df5233ccaa7, sha256 fcebe74f8238dface1b9691a9cdeb56410b223076123a9429545267f2bc8e2ac)

BibTeX

@misc{dc7df5233ccaa7,
  title = {Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma — Europe PMC PMID:40969261},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40969261},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7df5233ccaa7; sha256 fcebe74f8238dface1b9691a9cdeb56410b223076123a9429545267f2bc8e2ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40969261. Agents can read the archived copy with the MCP tool read_document.